Skip to content

Erzhitiangui granule in improving the outcomes of IVF/ICSI-ET in elderly patients with DOR:A prospective randomized, controlled, double-blind trial

Erzhitiangui granule in improving the outcomes of IVF/ICSI-ET in elderly patients with DOR:A prospective randomized, controlled, double-blind trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073736
Enrollment
Unknown
Registered
2023-07-19
Start date
2023-07-25
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diminished ovarian reserve

Interventions

Experimental Group:Erzhitiangui-Decoction
Control Group:placebo

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 42 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria of diminished ovarian reserve: AFC=5 or AMH=1.2ng/ml; ? Conforming to the syndrome differentiation standard of kidney Yin deficiency syndrome of TCM; ? Age of 35-42 years old; ? Sign the informed consent.

Exclusion criteria

Exclusion criteria: ? Premature ovarian failure, premature ovarian insufficiency, endometriosis, hyperprolactinemia and other diseases causing infertility; ?BMI < 18.5 or =30kg/m2; ? Complicated with other systemic diseases, such as diabetes, hyperthyroidism, heart disease, etc.; ? patients with a history of recurrent spontaneous abortion; ? chromosomal abnormalities; ? severe oligospermia, asthenospermia, teratozoospermia.

Design outcomes

Primary

MeasureTime frame
Cumulative clinical pregnancy rate;

Secondary

MeasureTime frame
TCM syndrome score of kidney Yin deficiency syndrome;Serum E2 and P4 levels on trigger day;2PN fertilization number;Number of embryos available;

Countries

China

Contacts

Public ContactLian Fang

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

lianfangbangong@163.com+86 137 0640 3122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026